|Articles|December 1, 2018
- Pharmaceutical Executive-12-01-2018
- Volume 38
- Issue 12
Pharmaceutical Executive, December 2018 Issue (PDF)
Click the title above to open the Pharmaceutical December 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 7 years ago
Science & Finance: The Biotech Blendalmost 7 years ago
Europe’s Digital Health Path Still at a Crossroadsalmost 7 years ago
Lessons for Pharma from the Merck Cyber Attackalmost 7 years ago
Securing a Winning Strategy for Real-World Evidencealmost 7 years ago
RWE: Answering Questions in Rare Diseasealmost 7 years ago
Measuring the Probability of Pricing and Access Successabout 7 years ago
Four Challenges for AI in the Life Sciencesabout 7 years ago
Country Report: MalaysiaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Trending on PharmExec
1
Report: Richard Pazdur Out as Director of CDER
2
Pharmaceutical Commercialization: A 2026 Outlook Personalization and Precision Will Define a New Year in Pharma
3
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
4
Regeneron Announces $150 Million Collaboration with Tessera Therapeutics to Develop Gene Editing Therapy
5
